Connect with us

Hi, what are you looking for?

Politics

Gilead Sciences’ remdesivir to be available for selected Covid-19 patients in the UK

Gilead Sciences Incs (NASDAQ:GILD) remdesivir will de administered to selected Covid-19 patients in ..

Gilead Sciences Incs (NASDAQ:GILD) remdesivir will de administered to selected Covid-19 patients in the UK.

The Medicines and Healthcare Products Regulatory Agency granted on Tuesday temporary access to the drug, which is not approved in any country.

READ: Gilead Sciences' remdesivir to be distributed in 127 countries[hhmc]

The government said that treatment will be prioritised for patients likely to benefit the most due to limited supplies.

Remdesivir is currently being used in the US and in Japan as an emergency treatment, while Gilead agreed licensing agreements with five generic pharmaceutical manufacturers to supply in 127 countries earlier this month.

Read More – Source
[contf]
[contfnew]

Proactiveinvestors

[contfnewc]
[contfnewc]

Finance

In an interview with ET Now, Dabur India Director Mohit Burm..

Science

The 147th Open championship will be at Carnoustie Golf Club in Scotland. Jan Kruger/R&A Golfers ..

Tech

Enlarge Oliver Morris/Getty Images) In response to an Ars re..

Tech

Enlarge/ You wouldn't really want to use Nvidia's ..